DELRAY BEACH, Fla., July 1, 2014 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID’s stockholders and the investment community on the Company’s recent developments and growth plans. Unrestricted access to the webcast is now available on the “Webcasts” page at http://www.thegreenbaron.com/Webcasts.htm .
About The Green Baron Report
The Green Baron Report is a subsidiary of Green Baron Ventures Inc. and can be found at www.TheGreenBaron.com. The Green Baron Report is an internet stock market newsletter that focuses on low priced stocks that appear to have significant upside potential. Investors who wish to receive The Green Baron Report for free can join at http://www.thegreenbaron.com/Join.htm. Our disclaimer can be viewed at http://www.thegreenbaron.com/Disclaimer.htm.
PositiveID’s M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) continuously and autonomously analyzes air samples for the detection of biological airborne threats in the form of bacteria, viruses, and toxins. The technology was developed under contract with the U.S. Department of Homeland Security Science & Technology directorate, which included $30 million of contract funding, to detect an attack with a biological weapon.
PositiveID’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results from a sample in less than 20 minutes at the point of need, compared to two to four hours for a lab device, using real-time TaqMan(R) PCR (polymerase chain reaction) chemistry. Firefly is being developed to meet the growing need for more rapid and accurate point-of-need diagnostics that will enable hospitals, first responders, and other providers to save lives.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements in the audio-taped interview with The Green Baron Report about PositiveID’s future expectations constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including the likelihood that PositiveID will be successful with its submissions for bids and proposals for U.S. government procurements for bio-threat detection, and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 11, 2014, and 10-Qs filed on May 20, 2014, November 19, 2013, and August 14, 2013, as amended August 19, 2013, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.